Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andres Cardona"'
Autor:
Oscar Arrieta, Luis Lara-Mejía, Patricia García López, Norma Hernández-Pedro, Graciela Cruz-Rico, David Heredia, Roberto Sánchez-Reyes, Cesar Infante-González, Aida Martínez Pérez, Venecia Matías-Cruz, Denise López Sámchez, Andres Cardona
Publikováno v:
Journal of Thoracic Oncology. 18:S8-S9
Autor:
Diego Chamorro, Andres Cardona, July Rodriguez, Alejandro Ruiz-Patiño, Oscar Arrieta, Darwin Moreno-Perez, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Dora Ardila, Lucia Viola, Gonzalo Recondo, Juan B. Blaquier, Claudio Martin, Luis E. Raez, Suraj Samtani, Camila Ordoñez-Reyes, Juan Esteban Garcia-Robledo, Luis Corrales, Carolina Sotelo, Luisa Ricaurte, Mauricio Cuello, Sergio Mejia, Elvira Jaller, Carlos Vargas, Alessandro Russo, Umberto Malapelle, Diego de Miguel Perez, Vladmir C. Cordeiro de Lima, Helano Freitas, Christian Rolfo, Rafael Rosell
Publikováno v:
Journal of Thoracic Oncology. 18:S4
Autor:
Diego De Miguel Perez, null Alessandro Russo, Luis Lara-Mejía, Marisol Arroyo-Hernández, Muthukumar Gunasekaran, Feliciano Barron, Andres Cardona, Christine Peterson, Rivka Colen, Aung Naing, Vincenzo Adamo, Oscar Arrieta, Christian Rolfo
Publikováno v:
Journal of Thoracic Oncology. 18:S6
Autor:
Martin Reck, Tony S.K. Mok, Aaron Mansfield, Richard De Boer, Gyorgy Losonczy, Shunichi Sugawara, Rafal Dziadziuszko, Maciej Krzakowski, Alexey Smolin, Maximilian Hochmair, Marina Chiara Garassino, Gilberto de Castro Junior, Helge Bischoff, Sivuonthanh Lam, Andres Cardona, Stefanie Morris, Stephen V. Liu
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(9)
In the phase 1/3 IMpower133 study, atezolizumab plus carboplatin and etoposide (CP/ET) followed by maintenance atezolizumab for first-line treatment of extensive-stage SCLC (ES-SCLC) led to improvement in both overall survival (OS) and progression-fr